Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/8329
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKigen, Gabriel-
dc.contributor.authorBusakhala, Naftali-
dc.contributor.authorOgaro, Francis-
dc.contributor.authorChesire, Emily-
dc.contributor.authorToo, Robert-
dc.contributor.authorNyandiko, Winstone-
dc.date.accessioned2023-11-08T12:53:47Z-
dc.date.available2023-11-08T12:53:47Z-
dc.date.issued2015-11-05-
dc.identifier.urihttp://ir.mu.ac.ke:8080/jspui/handle/123456789/8329-
dc.description.abstractCough syrups are widely used in the developing world, but safety of their use in infants and children less than two years has not been well documented. Some syrups contain multiple combinations of such drugs as promethazine, diphenhydramine and ephedrine; which are individually now contraindicated in children less than two years. Despite this, the syrups are available as over the counter drugs and may be dispensed to mothers who are unaware of the potentially hazardous effects to their infants. A descriptive cross-sectional study was used to investigate suitability of cough syrups sold within Eldoret municipality for use in chil- dren less than two years of age based on their formulations and available literature.en_US
dc.language.isoenen_US
dc.publisherPLOS ONEen_US
dc.subjectCough syrupsen_US
dc.subjectInfantsen_US
dc.subjectDeveloping worlden_US
dc.subjectHazardous effectsen_US
dc.titleA review of the Ingredients contained in over the counter (OTC) cough syrup formulations in Kenya. Are they harmful to Infants?en_US
dc.typeArticleen_US
Appears in Collections:School of Medicine

Files in This Item:
File Description SizeFormat 
Gabriel k.pdf218.49 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.